InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
0.00%
)
US TECH 100
19,145.60
(
-0.32%
)
Dow Jones
39,150.33
(
0.00%
)
Brent Oil
84.56
(
0.64%
)
Bitcoin
61,099.96
(
-3.26%
)
Post# of 252314
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DFRAI

Send PM Follow Ignore
Followers 19
Posts 1875
Boards Moderated 0
Alias Born 06/06/2006

DFRAI

Re: iwfal post# 109454

Wednesday, 11/24/2010 10:31:49 AM

Wednesday, November 24, 2010 10:31:49 AM

Post# of 252314
iwfal

MNTA is able to copy copaxone and characterize the entire structure. Why did FDA approve teva's copaxone if they did not know the MOA?
Why should FDA carry about MOA when MNTA will copy the strucutre and deliver sameness - hence a fully substitutable generic?????????????????????????????????
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up